Lynn A. Tetrault - Aug 10, 2024 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Director
Signature
/s/ Ali Olivo, Attorney-in-Fact
Stock symbol
NEO
Transactions as of
Aug 10, 2024
Transactions value $
$0
Form type
4
Date filed
8/13/2024, 04:37 PM
Previous filing
Jun 25, 2024
Next filing
Aug 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Options Exercise $0 +11.3K +22.64% $0.00 61.4K Aug 10, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Restricted Stock Unit Options Exercise $0 -11.3K -100% $0.00* 0 Aug 10, 2024 Common Stock 11.3K $0.00 Direct F2
holding NEO Stock Option (Right to Buy) 2.14K Aug 10, 2024 Common Stock 2.14K $22.52 Direct
holding NEO Stock Option (Right to Buy) 3.45K Aug 10, 2024 Common Stock 3.45K $28.54 Direct
holding NEO Stock Option (Right to Buy) 3.71K Aug 10, 2024 Common Stock 3.71K $40.90 Direct
holding NEO Stock Option (Right to Buy) 972 Aug 10, 2024 Common Stock 972 $41.76 Direct
holding NEO Stock Option (Right to Buy) 13.9K Aug 10, 2024 Common Stock 13.9K $8.10 Direct
holding NEO Stock Option (Right to Buy) 8.35K Aug 10, 2024 Common Stock 8.35K $14.82 Direct
holding NEO Stock Option (Right to Buy) 8.67K Aug 10, 2024 Common Stock 8.67K $13.71 Direct
holding NEO Restricted Stock Unit 12.3K Aug 10, 2024 Common Stock 12.3K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects release of restricted stock units that were previously reported on a Form 4.
F2 Once vested, the shares of common stock are not subject to expiration.